Literature DB >> 9826981

Common patterns of clinical motor dysfunction.

N H Mayer1, A Esquenazi, M K Childers.   

Abstract

An upper motor neuron syndrome often leads to the development of stereotypical patterns of deformity secondary to agonist muscle weakness, antagonist muscle spasticity and changes in the rheologic (stiffness) properties of spastic muscles. Identification of the spastic muscles that contribute to deformity across a joint allows therapeutic denervation to be implemented with the maximum likelihood of success. Identifying responsible muscles can be complex, since many muscles may cross the joint involved, and not all muscles with the potential to cause deformity will be spastic. Strategies including polyelectromyography and diagnostic blocks with local anesthetics can be used to test hypotheses regarding the deformity, providing information for more long-term denervation. In this review, we discuss frequently observed patterns of deformity associated with problematic spasticity, paresis, contracture, and impaired voluntary motor control.

Entities:  

Mesh:

Year:  1997        PMID: 9826981

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  18 in total

Review 1.  Neurologic disorders of gait.

Authors:  L Sudarsky
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

2.  Short-term effect of botulinum toxin a injection on spastic equinovarus foot in cerebral palsy patients: a study using the foot pressure measurement system.

Authors:  Su Min Son; In Sik Park; Jin Sun Yoo
Journal:  Ann Rehabil Med       Date:  2015-02-28

Review 3.  Botulinum toxin for the management of muscle overactivity and spasticity after stroke.

Authors:  A Esquenazi; N Mayer
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

4.  Lower extremity spasticity as an early marker of ambulatory recovery following traumatic brain injury.

Authors:  Helene M Dumas; Stephen M Haley; Tara M Carey; Larry H Ludlow; Jeffrey P Rabin
Journal:  Childs Nerv Syst       Date:  2003-02-01       Impact factor: 1.475

5.  Haptic recognition of dystonia and spasticity in simulated multi-joint hypertonia.

Authors:  D Piovesan; A Melendez-Calderon; F A Mussa-Ivaldi
Journal:  IEEE Int Conf Rehabil Robot       Date:  2013-06

6.  Therapist recognition of impaired muscle groups in simulated multi-joint hypertonia.

Authors:  A Melendez-Calderon; D Piovesan; F A Mussa-Ivaldi
Journal:  IEEE Int Conf Rehabil Robot       Date:  2013-06

7.  Three-dimensional kinematic analysis of upper and lower limb motion during gait of post-stroke patients.

Authors:  A A Carmo; A F R Kleiner; P H Lobo da Costa; R M L Barros
Journal:  Braz J Med Biol Res       Date:  2012-04-05       Impact factor: 2.590

8.  Efficacy and Optimal Dose of Botulinum Toxin A in Post-Stroke Lower Extremity Spasticity: A Systematic Review and Meta-Analysis.

Authors:  Thanh-Nhan Doan; Mei-Ying Kuo; Li-Wei Chou
Journal:  Toxins (Basel)       Date:  2021-06-18       Impact factor: 4.546

9.  A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

Authors:  Fábio Coelho Guarany; Paulo Dornelles Picon; Nicole Ruas Guarany; Antonio Cardoso dos Santos; Bianca Paula Mentz Chiella; Carolina Rocha Barone; Lúcia Costa Cabral Fendt; Pedro Schestatsky
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.